Imaging meetings & conferences

ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology (NEMB2013)

The ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology (NEMB2013) will be held February 4-6, 2013 in Boston, Massachusetts. The 2013 Congress will focus on the integration of engineering, materials science, and nanotechnology in addressing fundamental problems in biology and medicine and in developing devices, materials and methods for the early detection, imaging of pathological and physiological mechanisms, and treatment of disease.

Technical contributions will consist of oral and poster presentations, including plenary and invited keynote talks. Additional contributions will be presented by members of the engineering community, scientists, clinicians, students and experts from industry and will be focused on the development of new tools, methods and materials impacting biomedicine and life sciences, including nanomedicine and biologically inspired materials and technology.

The following areas will be the focus of NEMB2013:

Track 1 Bioengineering for Medical Diagnostics, Therapeutics and Imaging
Track 2 Nano-/Microfluidics in Biology and Medicine: Analysis, Diagnostics and Therapeutics
Track 3 Nanoengineering for Regenerative Medicine and Tissue Engineering
Track 4 Manufacturing and Materials for Nanomedicine, Biology and Nanoengineering
Track 5 Multiscale Modeling and Experiment in Biology and Medicine
Track 6 Biological Nanomechanics: Materials Factors in Physiology, Disease and Treatment
Track 7 Natural, Biomimetic and Bioinspired Materials and Structures
Track 8 Nanotechnology and Public Health

Tutorials on emerging topics of Nanoengineering for Medicine & Biology will be offered.

12th International Conference on Cancer-Induced Bone Disease

15 to 17 November, 2012 Lyon, France

The International Meeting on Cancer-Induced Bone Disease is among the most exciting international occasions for the exchange of the latest scientific discoveries. They are designed to allow attendees to enhance their knowledge of diseases of the skeleton, basic bone biology, mineral metabolism, and their correlation to oncology.

Discussions on the latest advances in innovative treatments and cutting-edge practices await you at the 2012 event. The conference takes place 15-17 November 2012 in Lyon, France. The world’s leading scientists and researchers will be on-hand to share their expertise in bone metastases and bone and cancer cell biology.

Learning Objectives
The importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
The role of cancer stem cells and hematopoietic stem cells in the metastatic process
The current state of the field of genomics and proteomics as applied to bone metastasis
The efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
The consequences of tumor cells on the skeleton
Understanding of the mechanisms of therapy resistance

IBMS and CABS meetings are premier international scientific events that provide an international forum to present and discuss current basic and clinical science in the rapidly advancing field of skeletal complications of cancer.

International Bone and Mineral Society (IBMS)
401 N Michigan Ave Chicago, Suite 2200, IL 60611 USA
Phone: +1 312-321-5113 | Fax: +1 312-673-6934 | Email: info@ibmsonline.org

Markers in Cancer 2012

October 11-13, 2012 Holywood, Florida

Markers in Cancer 2012 (formerly known as the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer) will stimulate discussion on the use of biomarkers as a tool for optimizing detection and treatment in oncology.

Designed for clinicians, pathologists, clinical and translational researchers, statisticians, radiologists, and others who specialize in molecular diagnostics, the meeting will present the latest advances in cancer markers to assess drug efficacy, improve prognostic and predictive evaluations and imaging, and enhance clinical trial development.

This year's Meeting will focus on practice-oriented translational research. Join us in Florida to review and explore the latest innovations in cancer markers.

Imaging Neurodegeneration and Repair in Multiple Sclerosis

June 15 - 16, 2012 The New York Academy of Sciences

Multiple Sclerosis (MS) was once difficult to diagnose, yet breakthroughs in Magnetic Resonance Imaging (MRI) now enable physicians to visualize newly forming lesions, give a diagnosis of MS, and start treatments with minimal invasiveness and greater accuracy. While conventional MRI studies have been able to establish white matter lesion formation as the major diagnostic criterion for MS, autopsy, animal models and newer imaging methods have shown that this damage is just the tip of the iceberg. Recent advances in imaging allow for the detailed visualization of grey matter, myelin, regional connectivity, and metabolic changes that provide vital clues to the extent MS can impact the central nervous system, and reveal neurobiological targets for new treatments.

This 1.5-day conference will provide an overview of the currently accepted and newly emerging imaging techniques for diagnosis and monitoring of MS. Participants will examine the benefits and limitations of standard and non-conventional imaging based on evidence from basic science research and clinical findings. Pharmacological treatments will be covered, with an emphasis on how imaging may be used to investigate treatment outcomes, including neuroprotection, remyelination, and neural repair, culminating in an open discussion devoted to integrating new imaging procedures in the clinic.

3rd Annual International Conference on Advances in Biotechnology (BioTech 2013)

18 - 19 March 2013 Singapore

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. The concept encompasses a wide range of procedures for modifying living organisms according to human purposes - going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization.

This multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.

Topics of interest include, but are not limited to:

Pharmaceutical / Medicine

• Structural Biology
• Proteomics
• Cell Cycle and Oncology
• Medical Microbiology
• Diagnostic Pathology
• Clinical Chemistry
• Haematology
• Diagnostic Imaging
• Medical Imaging and Methods
• Sonography
• Molecular and Cell Biology
• Biochemistry
• Immunology
• Genetics
• Neurobiology
• Drug production
• Pharmacogenomics
• Gene therapy
• Factors for transcribing DNA into RNA
• Monoclonol antibodies
• Pathogenesis of Human Diseases
• Presymptomatic testing

Food and Agriculture

• Genetic engineering
• Genomics
• Tissue culture
• Cell fusion
• Molecular biology
• Enzymology
• Fermentation processes
• Instrumentation and diagnostic methods
• Food processing
• Biofertilizer
• Waste Technology
• Environment Control
• Pest and diseases resistant crop
• High value addictives and chemical products
• Immunological techniques
• Signal transduction
• Conjugation
• Classical mutagenesis
• Conjugation process
• Hybridisation

CONFERENCE SECRETARIAT

Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162

For Conference Information info@advbiotech.org
For Registration, Accommodation or Visa Assistance secretariat@advbiotech.org

Cambridge Healthtech Institute Inaugural Innovative Tissue-Based Diagnostics Conference

June 4-5, 2012 Philadelphia, Pennsylvania

Innovative Tissue-Based Diagnostics is designed to feature recent breakthroughs in the field of pathology such as testing for predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. The goal of the conference is to enhance knowledge and experience exchange among industry and research pathologists as well as other researchers working with human tissue. This meeting will highlight the new generation of tissue-based diagnostic technologies aimed primarily towards molecular diagnostics of cancer. In addition, a session dedicated to the fascinating field of in vivo pathology will be offered.

KEY TAKE AWAYS:
• Learn about pathology's contribution and role in cancer drug development
• Get updates on how cancer pathology helps create genetically informed cancer medicine
• Learn how next generation sequencing has revolutionized genomics and is now on the verge of being widely adopted for medical sequencing
• Hear insights into in vivo microscopy and intra-operative optical imaging – a fascinating new and rapidly developing field of diagnostic medicine
• Get instructed on the challenges and solutions in assay development for the clinical setting

SESSIONS:

• Pathology in Cancer Drug Development
• Molecular Pathology as the Driving Force for Personalized Oncology
• Bridging Radiology-Pathology Divide

PRE-CONFERENCE SHORT COURSE - June 4 (9:00 am - 12:00 pm) Next-Generation Sequencing as a Diagnostics Platform

Cambridge Healthtech Institute:
250 First Avenue
Suite 300
Needham, MA 02494
Phone: 781-972-5400
Toll-Free: 888-999-6288
Fax: 781-972-5425
Web: www.chicorporate.com

Institute of Mathematics and Its Applications Conference on Mathematics of Medical Devices and Surgical Procedures

Monday 17 - Wednesday 19 September 2012 University College London United Kingdom

Mathematics is playing an ever increasing role in the area of health and medicine, through the use of modelling, statistics, and virtual simulations. These mathematical tools are becoming invaluable in testing the feasibility of surgical procedures and medical devices prior to clinical trials. Furthermore, there is a very realistic possibility over the next twenty years that computer models coupled to patient-specific imaging will be used in real time in the clinical environment to directly advise on treatment strategies. The aim of this conference is to bring together the diverse community of mathematicians, engineers, physicists, clinicians involved in using applied sciences and mathematics to develop and use medical devices to discuss both the latest research and the needs of the clinical community and patients.

The topics that will be discussed will broadly include cardiovascular devices, medical imaging, ophthalmology, cell biology, disease transmission, orthopaedic, advanced simulations, as well as health in ageing. The conference programme will include keynote speakers drawn from both clinical and mathematical communities, along with contributed presentations and poster sessions. The programme will also include breakout sessions in certain topics as well as refreshment breaks for informal discussions. Social events include a drinks reception and a conference dinner.

Contact information
For scientific queries please contact Ian Eames (i.eames@ucl.ac.uk) or Nick Ovenden (nicko@math.ucl.ac.uk).

For general conference queries please contact Lizzi Lake, Conference Officer
E-mail: conferences@ima.org.uk Tel: +44 (0) 1702 354 020
Institute of Mathematics and its Applications, Catherine Richards House, 16 Nelson Street, Southend-on-Sea, Essex, SS1 1EF, UK.

2nd International Scientific Tendinopathy Symposium (ISTS 2012)

September 27-29, 2012 Vancouver BC, Canada

The 2nd International Scientific Tendinopathy Symposium will bring together international leaders in tendinopathy research and clinical practice. Building on successes from the 1st meeting in Umea 2010, the ISTS 2012 aims to:

• Provide a forum for the latest clinical and basic research on tendinopathy.
• Foster the development of international partnerships for research and treatment.
• Host a weekend workshop (led by Bill Vicenzino and Jill Cook) on comprehensive physical therapy treatment for upper and lower extremity tendinopathies.

Society of Cardiovascular Computed Tomography 7th Annual Scientific Meeting

July 19-22, 2012 Baltimore, Maryland

3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the Intersection of the Lab, the Clinic and the Community

The American Medical Association (AMA) and the IEEE Engineering in Medicine and Biology (EMB) Society are pleased to announce the 3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the intersection of the lab, the clinic and the community in Houston, TX, on 7th-9th November 2012 at the Methodist Hospital Research Institute in the Texas Medical Center.

This conference is devoted to the exploration of the intersection of engineering, medicine, and health. Emphasis will be placed on novel innovations that have a foreseeable impact on human health and disease. Specific areas of interest include Imaging; Nano Medicine; Data Mining and the Use of Large Datasets; Remote Sensing; Networks & Communication; Applied Metabolomics; Aerospace and Harsh Environments; and Global Health.

We invite participation by physicians, nurses and other healthcare professionals, engineers, innovators, entrepreneurs, industrial leaders, government agencies and policy makers. The conference will be inaugurated by a keynote lecture and evening reception on Wednesday, 7th November. The following two days will feature plenary, break-out sessions and poster presentations focusing on Translational Engineering in Health & Medicine.